← All trials
NCT06785571
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 30, 2023
- Primary completion
- Oct 31, 2025
- Completion date
- Oct 31, 2025
- First posted
- Jan 21, 2025
- Last posted
- Jan 21, 2025
- Enrollment
- 204
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Huazhong University of Science and TechnologyLead sponsor
- Yichang Humanwell Pharmaceutical Co.,LtdCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.